Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

ALRN-6924 may prevent hair loss caused by chemotherapy.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

JAK inhibitors effectively treat inflammatory skin diseases by targeting specific cytokine signals.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

The compound 4c effectively inhibits the enzyme linked to hair loss.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

JAK inhibitors might help treat alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.